204 related articles for article (PubMed ID: 19818852)
1. Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease.
Miller BR; Walker AG; Fowler SC; von Hörsten S; Riess O; Johnson MA; Rebec GV
Neurobiol Dis; 2010 Jan; 37(1):106-13. PubMed ID: 19818852
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.
Miller BR; Walker AG; Shah AS; Barton SJ; Rebec GV
J Neurophysiol; 2008 Oct; 100(4):2205-16. PubMed ID: 18667541
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease.
Miller BR; Walker AG; Barton SJ; Rebec GV
Front Syst Neurosci; 2011; 5():26. PubMed ID: 21629717
[TBL] [Abstract][Full Text] [Related]
4. Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease.
Fernández-García S; Orlandi JG; García-Díaz Barriga GA; Rodríguez MJ; Masana M; Soriano J; Alberch J
BMC Biol; 2020 May; 18(1):58. PubMed ID: 32466798
[TBL] [Abstract][Full Text] [Related]
5. Altered information processing in the prefrontal cortex of Huntington's disease mouse models.
Walker AG; Miller BR; Fritsch JN; Barton SJ; Rebec GV
J Neurosci; 2008 Sep; 28(36):8973-82. PubMed ID: 18768691
[TBL] [Abstract][Full Text] [Related]
6. Motor function and dopamine release measurements in transgenic Huntington's disease model rats.
Ortiz AN; Osterhaus GL; Lauderdale K; Mahoney L; Fowler SC; von Hörsten S; Riess O; Johnson MA
Brain Res; 2012 Apr; 1450():148-56. PubMed ID: 22418060
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene.
Rebec GV; Barton SJ; Ennis MD
J Neurosci; 2002 Jan; 22(2):RC202. PubMed ID: 11784814
[TBL] [Abstract][Full Text] [Related]
8. Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.
Mantovani S; Gordon R; Li R; Christie DC; Kumar V; Woodruff TM
Hum Mol Genet; 2016 May; 25(9):1780-91. PubMed ID: 26908618
[TBL] [Abstract][Full Text] [Related]
9. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
Chen MT; Morales M; Woodward DJ; Hoffer BJ; Janak PH
Exp Neurol; 2001 Sep; 171(1):72-83. PubMed ID: 11520122
[TBL] [Abstract][Full Text] [Related]
10. Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease.
Rossi S; Prosperetti C; Picconi B; De Chiara V; Mataluni G; Bernardi G; Calabresi P; Centonze D
Neurosci Lett; 2006 Dec; 410(1):6-10. PubMed ID: 17070651
[TBL] [Abstract][Full Text] [Related]
11. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
12. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
Farrar AM; Callahan JW; Abercrombie ED
Exp Neurol; 2011 Dec; 232(2):119-25. PubMed ID: 21864528
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model.
Sepers MD; Smith-Dijak A; LeDue J; Kolodziejczyk K; Mackie K; Raymond LA
J Neurosci; 2018 Jan; 38(3):544-554. PubMed ID: 29192125
[TBL] [Abstract][Full Text] [Related]
14. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
Rebec GV; Conroy SK; Barton SJ
Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
[TBL] [Abstract][Full Text] [Related]
15. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats.
Kántor O; Temel Y; Holzmann C; Raber K; Nguyen HP; Cao C; Türkoglu HO; Rutten BP; Visser-Vandewalle V; Steinbusch HW; Blokland A; Korr H; Riess O; von Hörsten S; Schmitz C
Neurobiol Dis; 2006 Jun; 22(3):538-47. PubMed ID: 16480885
[TBL] [Abstract][Full Text] [Related]
16. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
Chen GJ; Jeng CH; Lin SZ; Tsai SH; Wang Y; Chiang YH
J Biomed Sci; 2002; 9(4):303-10. PubMed ID: 12145527
[TBL] [Abstract][Full Text] [Related]
17. Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease.
Dai Y; Dudek NL; Li Q; Fowler SC; Muma NA
J Neurosci; 2009 Sep; 29(37):11550-9. PubMed ID: 19759302
[TBL] [Abstract][Full Text] [Related]
18. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
Reynolds DS; Carter RJ; Morton AJ
J Neurosci; 1998 Dec; 18(23):10116-27. PubMed ID: 9822765
[TBL] [Abstract][Full Text] [Related]
19. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
Barry J; Akopian G; Cepeda C; Levine MS
J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
[TBL] [Abstract][Full Text] [Related]
20. Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.
Holley SM; Galvan L; Kamdjou T; Cepeda C; Levine MS
Eur J Neurosci; 2019 Jan; 49(1):79-93. PubMed ID: 30472747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
